Replies to post #43669 on Savvy Trades and Investments

[SSKILLZ1]

Littlefish (On ZYXI) if you look at absolute numbers it sounds not great, but if you really dig further and think about it there is nothing wrong. here is why?

You make it sound omninous but in reality gp% was 76% last year this time, and now it is 80% with increased sales and economies of scale, going from 76% to 80% would be normal fluctuation to me anyways one way or the other. so this idea that there is something wrong here, they have a high gp %, so cogs isn't gonna go up nearly as much as sales because for every 1 million in sales they add they only add 200k in cogs, this isn't nothing new by the way this is around the companies normal historical GP %. So yes what your saying sounds omnious at first but if you really break out the numbers shouldn't be omnious but rather expected in my opinion. All is just my opinion, and I could always be wrong though.

[Knowledge is King]

ZYXI($3.44) adds a couple heavy-hitters to the Board. Up-list in sight?

The Board of Directors has appointed Messrs. Barry D. Michaels and Michael Cress to serve as members of the Board of Directors of Zynex, Inc., a Nevada corporation (the “Company”). The appointments are effective January 10, 2018.



The following is biographical information on Mr. Michaels:



Mr. Michaels, age 67, is a retired senior executive with both general and financial management experience in emerging growth companies. Mr. Michaels has more than 35 years of financial and general management experience in the medical device and biotechnology industries with industry leaders including Medtronic, Johnson and Johnson, and Baxter Healthcare. Mr. Michaels served as Chief Financial Officer of three private and four publicly traded companies including Cardima, Inc., Lipid Sciences, Inc., ICN Biomedicals, Inc., IntraTherapeutics, Inc., VIA Medical, and Webster Laboratories. In addition he served as President of a Johnson and Johnson division and acting Chief Executive Officer of Lipid Sciences, Inc. He has raised nearly $800 million in capital within public and private market environments, has taken two companies public, and has led three private companies to favorable liquidity events. He has also served as an independent consultant to medical device and biotechnology companies since 1997 leveraging his strong mix of organizational, operational, and financial management skills to advise senior management and directors. During his tenure in executive management Mr. Michaels has added over 1,100 jobs to the economy and increased shareholder value by more than $2 billion.



Mr. Michaels holds BA in Audiology and an MBA in Finance from San Diego State University and is a graduate of the Executive Program at the University of California, Los Angeles. In addition, he has completed the UCLA Director’s Education Program certification exam and has served as Corporate Secretary to three publicly traded companies.



Mr. Michaels has also been appointed Audit Committee Chair of the Company’s Audit Committee. Mr. Michaels qualifies as an audit committee financial expert within the meaning of Section 407 of the Sarbanes-Oxley Act of 2002 and Item 407(d)(5) of Regulation S-K.



The following is biographical information on Mr. Cress:



Mr. Cress, age 60, currently serves as Chairman and Managing Partner of MD Cress Ventures, a national firm that owns, operates and advises companies within the healthcare sector. Mr. Cress also serves as Chairman of Rainier Healthcare. Prior to MD Cress Ventures he served as the President and CEO of the Cornerstone Healthcare Group which owns and manages hospitals throughout the country. Mr. Cress also served as Vice President of Business Development for Kindred Healthcare, a publicly traded healthcare company that owns and operates hospitals, nursing homes, rehabilitation, pharmacy and other segments of the healthcare continuum. He served as the CEO of Vencor Hospital of San Diego and was also an Adjunct Professor for the Masters of Healthcare Administration program at the University of Kansas. Mr. Cress currently serves on several not-for-profit boards including Rachel’s Challenge and is a co-founder and board member for The Neighborhood as well as serving on the boards or advisory boards of several companies, including Linley Capital, BankSNB, Rainier Hospice and Sleep Research.